Insider Transactions in Q2 2021 at Eton Pharmaceuticals, Inc. (ETON)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2021
|
Opaleye Management Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
105,000
-2.76%
|
$840,000
$8.07 P/Share
|
|
Jun 03
2021
|
Sean Brynjelsen President & CEO |
BUY
Open market or private purchase
|
Direct |
5,000
+0.48%
|
$25,000
$5.96 P/Share
|
|
May 27
2021
|
Opaleye Management Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
126,000
-3.14%
|
$1,008,000
$8.49 P/Share
|
|
May 26
2021
|
Opaleye Management Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
68,300
-1.77%
|
$546,400
$8.57 P/Share
|
|
May 25
2021
|
Opaleye Management Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
48,000
-1.24%
|
$384,000
$8.53 P/Share
|
|
Apr 12
2021
|
Harrow Health, Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,518,000
-43.37%
|
$10,626,000
$7.0 P/Share
|